These include clinical trials focused on the beneficial effects of TC derivatives (particularly doxycycline and minocycline) on amyloidogenic disorders, including Alzheimer (AD), Parkinson (PD), Huntington (HD) diseases and TTR. The gene discussed is TTR; the disease is Parkinson disease.